Medicenna Therapeutics Corp.

News & Events

Press Releases

In The Media

1. Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update

   GlobeNewswire NOV 13, 2025 7:00 AM EST
   Updated MDNA11 Clinical Data from the ABILITY-1 Study will be Presented at the European Society f...
   Read Article

2. Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, "NEO-CYT", in High-Risk, Surgically Resectable Stage III Melanoma

   GlobeNewswire NOV 6, 2025 7:00 AM EST
   NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery...
   Read Article

3. Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

   GlobeNewswire OCT 23, 2025 5:12 PM EDT
   TORONTO and HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medi...
   Read Article

4. Medicenna Therapeutics Announces Participation in Upcoming Conferences

   GlobeNewswire OCT 20, 2025 7:00 AM EDT
   TORONTO and HOUSTON, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (&#...
   Read Article

5. ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City

   GlobeNewswire OCT 1, 2025 9:35 AM EDT
   NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH&#...
   Read Article

6. Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

   GlobeNewswire OCT 1, 2025 7:00 AM EDT
   TORONTO and HOUSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (&#...
   Read Article

7. Medicenna Announces Results of Annual Meeting of Shareholders

   GlobeNewswire SEP 25, 2025 5:00 PM EDT
   TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (&...
   Read Article

8. Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

   GlobeNewswire SEP 5, 2025 7:00 AM EDT
   TORONTO and HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (&...
   Read Article

9. Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights

   GlobeNewswire AUG 1, 2025 7:00 AM EDT
   Updated cash guidance provides runway into at least the middle of calendar 2026 Company r...
   Read Article

10. Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines

    GlobeNewswire JUL 31, 2025 7:00 AM EDT
    TORONTO and HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (&#...
    Read Article